AbbVie (ABBV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2024, AbbVie (ABBV) reported revenue of $14.46 billion, up 4.3% over the same period last year. EPS came in at $2.65, compared to $2.91 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $14.05 billion, representing a surprise of +2.96%. The company delivered an EPS surprise of +3.11%, with the consensus EPS estimate being $2.57.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they com ...